Takeda Declines to Exercise Option for Wave's WVE-003
Wave Stock Soars 38% on Positive Data for AATD Therapy WVE-006
Express News | ViiV Healthcare, Owned By GSK, Pfizer And Shionogi, Announced The Presentation Of New Real-world Evidence And Implementation Data Showing The Effectiveness, Adherence, And Quality-of-life Improvement Of Apretude (Cabotegravir Long-acting) For HIV...
Express News | The FDA Has Accepted Us Marketing Application For GSK's Gepotidacin, An Oral Antibiotic For Adult And Adolescent Females For Uncomplicated Urinary Tract Infections, 26 March 2025 Assigned As Action Date For FDA Decision
GSK's UTI Treatment Gets Accepted for Priority Review by U.S.'s FDA
Express News | Glaxosmithkline Sues Moderna for U.S. Patent Infringement Over Mrna Technology in Covid-19 Vaccines - Court Filing
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Gritstone Oncology (GRTS) and Immutep (IMMP)
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
GSK Says ANCHOR Trials for Depemokimab Met Primary Endpoints
Stocks to Watch Monday: Tesla, Boeing, Vulcan Materials, GSK -- WSJ
glaxosmithkline (GSK.US) experimental drug Depemokimab for the treatment of rhinitis trial achieved positive results
An experimental drug developed by GlaxoSmithKline for the treatment of a common type of rhinitis has shown positive results in two late-stage trials, which has boosted the research and development pipeline of this united kingdom pharmaceutical company.
GSK Respiratory Drug Shows Efficacy for Rhinosinusitis in Late-Stage Trials
GSK Announces Positive Phase III Results From ANCHOR Trials for Depemokimab in Chronic Rhinosinusitis With Nasal Polyps
GlaxoSmithKline (GSK) Gets a Hold From Kepler Capital
Jim Cramer Says GSK Plc (GSK) 'Goes Higher'
Express News | State Reports Six Human Bird Flu Cases Now Confirmed in California - CDPH
GSK Settles Majority Of Zantac Lawsuits, But Pipeline Doubts Remain
European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading
Gilead's HIV Prevention Treatment Lenacapavir Shows Potential
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice